Blog
Researchers Identify New Potential Treatment for Melanoma, SCC
By Joe Gorelick, MSN, FNP-C An investigational anti-tumor compound may have efficacy against melanoma and squamous cell carcinoma (SCC), as well as lung cancer, researchers say. Plixorafenib (also called PLX8394) is currently in phase 2 clinical trials for melanoma...
Biologic Research Studies Lack Subject Images
In the published studies for biologic treatments for psoriasis, available images account for fewer than one subject per 1,000 participants, a new analysis concludes. More than three-quarters (77%) of studies contain no images at all. Researchers analyzed 152 different...
3D Printed Hair Follicles: Now What?
Researchers have successfully 3D-printed hair follicles in cultured human skin tissues, but potential applications for direct patient use won’t be seen for some time. Instead, the development could be used in drug testing, since hair follicles are an entry point for...
How to Respond to the “Sunscreen Paradox”
By Joe Gorelick, MSN, FNP-C Rates of melanoma and non-melanoma skin cancer continue to rise, even as sunscreen use increases. According to researchers from McGill University, this “sunscreen paradox” reflects the tendency of individuals to view sunscreen use as...
Aesthetic Dermatology Basics: Dermalorian™ Podcast November Edition
Medical and cosmetic dermatology often overlap, says dermatologist and DERM 2023 faculty member Gilly Munavalli, MD. Along with fellow faculty member Suneel Chilukuri, MD, he discussed basic aesthetic interventions that may be appropriate for most practices. They...
Safe Prescribing by NPs Mirrors That by Physicians
By Joe Gorelick, MSN, FNP-C Are nurse practitioners any more likely than primary care physicians to inappropriately prescribe drugs to older patients? Findings from a comprehensive analysis of prescribing patterns in 29 states over six years indicate they are not. In...
FDA Approves Cosentyx to Treat HS
Cosentyx® (secukinumab) from Novartis is now approved to treat moderate to severe hidradenitis suppurativa (HS) in adults. Cosentyx is the only FDA-approved fully human biologic that directly inhibits interleukin-17A (IL-17A), a cytokine believed to be involved in the...
It’s National Biologic Coordinator’s Day
As the field of biologic and small molecule therapies has taken shape and grown in the last two decades, so has the role of the Biologic Coordinator or Access Specialist. Across multiple medical specialties, Biologic Coordinators fill an administrative role in the...
Atopic Dermatitis in Skin of Color
Kristine Kucera, PA-C, MPAS, DHS Atopic dermatitis is more prevalent in African American (19.3%), compared with European American children. Yet, challenges in diagnosing and treating atopic dermatitis in individuals with skin of color persist. These challenges...
Skin Disease and Mental Health: What to Know
Kristine Kucera, PA-C, MPAS, DHS The World Health Organization declared October 10 Mental Health Day. With this, they acknowledged the hidden burdens of skin disease. A large survey focused on patients suffering from dermatological conditions showed that mental...